Fig. 6From: 18F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomographyEffect of pre-blocking of PS using (Ă—Â 10) molar excess of unlabeled C2Am on 18F-C2Am tumor contrast in MEDI3039-treated mice (0.4Â mg/kg, 24Â h, i.v.) bearing MDA-MB-231 tumors. Red lined triangles (18F-C2Am; no pre-blocking); black lined squares (18F-C2Am; 10x pre-blocking with C2Am)Back to article page